The stock's fall snapped a four-day winning streak.

Elevance Health Inc. closed 26.44% below its 52-week high of $567.26, which the company reached on September 3rd.

Stocks closed higher Wednesday as the Federal Reserve decided to leave its key interest rate unchanged while noting that the ...

Last month’s technology laggard among the Dow’s constituents ... where he questioned the health insurer's reported profits and suggested the stock was a short-selling candidate.

Tom Lee, co-founder of Fundstrat Global Advisors, believes that a significant rebound is in the […] Among the blue-chip-laden Dow Jones Industrial Average ... questioned the health insurer's ...

More than 150 years of back-tested data paints a clear picture of what may come next for Wall Street's major stock indexes.

Argus upgraded Elevance Health (ELV) to Buy from Hold with a $450 price target Light Up your Portfolio with Spark:Easily identify stocks' risks ...

The following are the pivot points for the SPDR Dow Jones Industrial Average ETF Trust (DIA). Pivot High: $415.76, Pivot Low: $408.75. These were calculated using the DeMark method. It is ...

Regulatory changes under Trump's administration and AI integration are key factors influencing Elevance Health's future ...

The Dow Jones Industrial Average (DJIA) fell some 400 points on Thursday, declining around one full percent after United States (US) President Donald Trump and his administration ramped up their ...

Equities shrugged off one of the worst consumer sentiment prints in years. The Dow Jones Industrial Average (DJIA) fought back at the brink on Friday, clawing back roughly 520 points following a ...